Anhui Provincial Hospital
Clinical trials sponsored by Anhui Provincial Hospital, explained in plain language.
-
New radiation combo shows promise for tough lung cancers
Disease control CompletedThis study tested a new way of giving radiation therapy combined with immunotherapy for people with advanced non-small cell lung cancer that does not have certain genetic mutations. The goal was to see if mixing high-dose and low-dose radiation could help the immune system fight …
Phase: PHASE2 • Sponsor: Anhui Provincial Hospital • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
Experimental MegaLT injection targets dangerous low platelets in early trial
Disease control CompletedThis early-phase trial tests a new cell therapy called MegaLT for people with dangerously low platelet counts that don't improve after radiation, chemotherapy, or stem cell transplant. Only 10 participants will receive the injection at different doses to check safety and how the …
Phase: PHASE1 • Sponsor: Anhui Provincial Hospital • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
Tailored meals boost recovery after liver cancer surgery
Symptom relief CompletedThis study tested whether a personalized diet plan helps liver cancer patients eat more and recover faster after surgery. 139 patients who had part of their liver removed were split into two groups: one got standard care, the other got a custom meal plan with extra protein drinks…
Phase: NA • Sponsor: Anhui Provincial Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 08:12 UTC
-
Artificial intelligence could help guide liver cancer treatment after surgery
Knowledge-focused CompletedThis study developed an artificial intelligence model that analyzes MRI scans and pathology images to predict the risk of liver cancer returning after surgery. Researchers used data from over 500 patients who had their liver cancer surgically removed. The goal is to help doctors …
Sponsor: Anhui Provincial Hospital • Aim: Knowledge-focused
Last updated Jul 15, 2026 00:00 UTC
-
AI model may personalize liver cancer care after surgery
Knowledge-focused CompletedThis study analyzed data from 1005 liver cancer patients to see who benefits from a treatment called TACE after surgery. Using machine learning, researchers aimed to predict individual patient outcomes. The goal is to help doctors decide whether to recommend TACE or just monitor …
Sponsor: Anhui Provincial Hospital • Aim: Knowledge-focused
Last updated Jul 11, 2026 00:00 UTC